Cresco Labs Inc.
CRLBF
$0.76
$0.00-0.40%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.83% | -7.70% | -5.74% | -4.39% | -4.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.83% | -7.70% | -5.74% | -4.39% | -4.36% |
| Cost of Revenue | -4.21% | -6.73% | -9.52% | -11.90% | -15.92% |
| Gross Profit | -13.28% | -8.67% | -1.55% | 4.44% | 10.28% |
| SG&A Expenses | -2.30% | -1.27% | -2.53% | -10.59% | -19.64% |
| Depreciation & Amortization | -21.38% | -21.85% | -16.28% | -11.28% | 27.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.24% | -5.36% | -7.25% | -11.39% | -16.13% |
| Operating Income | -32.36% | -20.69% | 5.11% | 68.11% | 241.92% |
| Income Before Tax | -511.96% | 112.33% | 77.09% | 92.77% | 99.73% |
| Income Tax Expenses | -17.70% | 72.72% | 35.27% | 51.36% | 13.22% |
| Earnings from Continuing Operations | 9.64% | 77.52% | 52.19% | 66.37% | 84.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 86.49% | 12.71% | -1,659.05% | -422.15% | -143.99% |
| Net Income | 22.60% | 73.51% | 45.90% | 57.59% | 80.14% |
| EBIT | -32.36% | -20.69% | 5.11% | 68.11% | 241.92% |
| EBITDA | -28.26% | -19.72% | -2.25% | 32.48% | 101.82% |
| EPS Basic | 24.23% | 74.34% | 48.20% | 59.83% | 81.89% |
| Normalized Basic EPS | 230.70% | 175.07% | -235.69% | -481.75% | -195.76% |
| EPS Diluted | 24.23% | 74.34% | 48.20% | 59.83% | 81.89% |
| Normalized Diluted EPS | 230.70% | 175.07% | -235.69% | -481.75% | -195.76% |
| Average Basic Shares Outstanding | 2.55% | 2.69% | 4.40% | 6.72% | 9.13% |
| Average Diluted Shares Outstanding | 2.55% | 2.69% | 4.40% | 6.72% | 9.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |